WO2002072020A3 - Nouveaux composes anti-adhesifs et leurs utilisations - Google Patents

Nouveaux composes anti-adhesifs et leurs utilisations Download PDF

Info

Publication number
WO2002072020A3
WO2002072020A3 PCT/US2002/007426 US0207426W WO02072020A3 WO 2002072020 A3 WO2002072020 A3 WO 2002072020A3 US 0207426 W US0207426 W US 0207426W WO 02072020 A3 WO02072020 A3 WO 02072020A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
novel anti
adhesive compounds
methods
fouling
Prior art date
Application number
PCT/US2002/007426
Other languages
English (en)
Other versions
WO2002072020A2 (fr
Inventor
Randall S Alberte
Robert D Smith
Original Assignee
Cerno Biosciences Llc
Randall S Alberte
Robert D Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerno Biosciences Llc, Randall S Alberte, Robert D Smith filed Critical Cerno Biosciences Llc
Priority to AU2002255704A priority Critical patent/AU2002255704A1/en
Priority to EP02725119A priority patent/EP1385821A4/fr
Priority to CA002441174A priority patent/CA2441174A1/fr
Priority to JP2002570980A priority patent/JP4363850B2/ja
Publication of WO2002072020A2 publication Critical patent/WO2002072020A2/fr
Publication of WO2002072020A3 publication Critical patent/WO2002072020A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/14—Libraries containing macromolecular compounds and not covered by groups C40B40/06 - C40B40/12
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14—Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Structural Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

L'invention concerne des composés présentant des propriétés anti-adhésives. Ces composés peuvent être des monomères ou des polymères. L'invention concerne également des méthodes de traitement de maladies induites par un récepteur au moyen des composés selon l'invention. L'invention concerne encore des procédés de protection des cultures, des dispositifs médicaux et des anti-parasites.
PCT/US2002/007426 2001-03-12 2002-03-12 Nouveaux composes anti-adhesifs et leurs utilisations WO2002072020A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU2002255704A AU2002255704A1 (en) 2001-03-12 2002-03-12 Novel anti-adhesive compounds and uses thereof
EP02725119A EP1385821A4 (fr) 2001-03-12 2002-03-12 Nouveaux composes anti-adhesifs et leurs utilisations
CA002441174A CA2441174A1 (fr) 2001-03-12 2002-03-12 Nouveaux composes anti-adhesifs et leurs utilisations
JP2002570980A JP4363850B2 (ja) 2001-03-12 2002-03-12 新規な抗付着化合物およびそれらの使用

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27522301P 2001-03-12 2001-03-12
US60/275,223 2001-03-12

Publications (2)

Publication Number Publication Date
WO2002072020A2 WO2002072020A2 (fr) 2002-09-19
WO2002072020A3 true WO2002072020A3 (fr) 2003-11-27

Family

ID=23051374

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/007426 WO2002072020A2 (fr) 2001-03-12 2002-03-12 Nouveaux composes anti-adhesifs et leurs utilisations

Country Status (5)

Country Link
EP (1) EP1385821A4 (fr)
JP (2) JP4363850B2 (fr)
AU (1) AU2002255704A1 (fr)
CA (1) CA2441174A1 (fr)
WO (1) WO2002072020A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700819B2 (en) 2001-02-16 2010-04-20 Kci Licensing, Inc. Biocompatible wound dressing
US7763769B2 (en) 2001-02-16 2010-07-27 Kci Licensing, Inc. Biocompatible wound dressing
DE10246625A1 (de) 2002-10-07 2004-04-15 Basf Ag Verfahren zum Abtöten von Mikroorganismen
EP2081565A2 (fr) * 2006-10-13 2009-07-29 Reliance Life Sciences Pvt., Ltd. Nouveaux agents chimiothérapeutiques contre l'inflammation et le cancer
CN103923243B (zh) * 2014-04-11 2016-06-01 东南大学 一种旋光聚乙炔红外低发射率材料及其制备方法
EP3393598B1 (fr) 2015-12-24 2020-11-11 Unilever NV Materiel composite pour la controle du biofilm

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3331798A (en) * 1962-01-08 1967-07-18 Dow Chemical Co Viscous aqueous blend of polystyrene sulfonate and n-vinylpyrrolidinone, and preparation thereof
US3432454A (en) * 1965-03-24 1969-03-11 Dow Chemical Co Viscous aqueous compositions comprising a polymer containing n-vinyl morpholinone and a polymer containing sulfo or carboxyl groups or their salts
US4507235A (en) * 1979-04-30 1985-03-26 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for preparing peptides and intermediate products
US5208316A (en) * 1990-10-01 1993-05-04 Toppan Printing Co., Ltd. Cyclodextrin polymer and cyclodextrin membrane prepared using said polymer
US5294530A (en) * 1991-05-17 1994-03-15 Fuji Photo Film Co., Ltd. Silver halide color photographic material
EP0801117A2 (fr) * 1996-04-11 1997-10-15 Nippon Paint Co., Ltd. Composition de résine anti-salissure
EP0596023B1 (fr) * 1991-07-19 1998-10-14 J.C. Hempel's Skibsfarve-Fabrik A/S Composition de peinture

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375461A (en) * 1980-07-25 1983-03-01 Johnson & Johnson Products, Inc. Sulfonated vinyl aromatic homopolymers and copolymers as dental plaque barriers
EP0796634B1 (fr) * 1996-03-21 2005-11-16 BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro Berlin Electrode de stimulation implantable
WO2000016623A1 (fr) * 1998-09-23 2000-03-30 Phycogen, Inc. Agents antisalissures
WO2001074762A2 (fr) * 2000-04-03 2001-10-11 Phycogen, Inc. Generation de bibliotheques combinatoires synthetiques et criblage de nouvelles proadhesines et nonadhesines

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3331798A (en) * 1962-01-08 1967-07-18 Dow Chemical Co Viscous aqueous blend of polystyrene sulfonate and n-vinylpyrrolidinone, and preparation thereof
US3432454A (en) * 1965-03-24 1969-03-11 Dow Chemical Co Viscous aqueous compositions comprising a polymer containing n-vinyl morpholinone and a polymer containing sulfo or carboxyl groups or their salts
US4507235A (en) * 1979-04-30 1985-03-26 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for preparing peptides and intermediate products
US5208316A (en) * 1990-10-01 1993-05-04 Toppan Printing Co., Ltd. Cyclodextrin polymer and cyclodextrin membrane prepared using said polymer
US5294530A (en) * 1991-05-17 1994-03-15 Fuji Photo Film Co., Ltd. Silver halide color photographic material
EP0596023B1 (fr) * 1991-07-19 1998-10-14 J.C. Hempel's Skibsfarve-Fabrik A/S Composition de peinture
EP0801117A2 (fr) * 1996-04-11 1997-10-15 Nippon Paint Co., Ltd. Composition de résine anti-salissure

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NUZILLARD J.M., TETRAHEDRON LETTERS, vol. 27, no. 26, 1986, pages 2993 - 2996, XP002963674 *
See also references of EP1385821A4 *

Also Published As

Publication number Publication date
EP1385821A4 (fr) 2006-03-08
EP1385821A2 (fr) 2004-02-04
JP2009149688A (ja) 2009-07-09
WO2002072020A2 (fr) 2002-09-19
AU2002255704A1 (en) 2002-09-24
CA2441174A1 (fr) 2002-09-19
JP4363850B2 (ja) 2009-11-11
JP2004533416A (ja) 2004-11-04

Similar Documents

Publication Publication Date Title
WO2007030266A3 (fr) Polymeres a liberation d'acide nitrique derives de polyimines modifiees
WO2003101397A3 (fr) Vaccins tetravalents contre la dengue
WO2004006858A3 (fr) Composes, compositions et methodes d'utilisation de ces derniers
WO2006002437A3 (fr) Traitement d'etats pathologiques impliquant la demyelinisation
AU2003249736A1 (en) Purified polymers for coatings of implantable medical devices
WO1999029353A3 (fr) Instruments medicaux a proprietes ameliorees
WO2004009062A3 (fr) Antagonistes du recepteur nmda et leur utilisation pour inhiber l'hyperphosphorylation de la proteine associee aux microtubules tau
WO2003005999A8 (fr) Methodes permettant de traiter des maladies induites par les cytokines
HK1092467A1 (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses n-
AU2002254158A1 (en) Medical devices, compositions and methods for treating vulnerable plaque
WO2004028454A3 (fr) 1, 3, 5-triazines destinees au traitement de maladies virales
WO2007010034A3 (fr) Copolymere ampholyte, sa production et son utilisation
WO2004045464A3 (fr) Dispositifs medicaux
AU2002364300A1 (en) Polymer derivatives for the treatment of metals
WO2007056134A3 (fr) Polymeres phenoliques resorbables
WO2005021497A3 (fr) Trimeres et dimeres fixes de 1,4-diphenylazetidin-2-ones
WO2002103103A3 (fr) Composes contenant du fluor et polymeres derives de ces composes
WO2007024481A3 (fr) Compositions polymeres a base de 4-aza-caprolactone utiles pour la fabrication de dispositifs medicaux biodegradables et en tant que revetements pour dispositifs medicaux
WO2009094361A3 (fr) Polymères conjugués de 3,4-propylènedioxythiophène substitué, leur composition, leur procédé de fabrication et leur utilisation
WO2005051325A3 (fr) Base libre de carvedilol, ses sels, formes anhydres ou solvats, compositions pharmaceutiques correspondantes, formulations a liberation controlee, et methodes de traitement ou d'administration
WO2006043984A3 (fr) Polymeres d'amine reticules
AU2002356513A1 (en) Triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers
WO2001017543A3 (fr) Compositions et procedes permettant la prevention ou le traitement du cancer et de la perte osseuse associee au cancer
WO2009015336A3 (fr) Produits médicamenteux d'interféron à libération régulée et traitement d'une infection par hcv utilisant ceux-ci
WO2002073208A3 (fr) Agents antiepileptogenes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2441174

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002570980

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002725119

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002725119

Country of ref document: EP